Enhancing life sciences research with generative AI 

Promising use cases 

Use cases are emerging that apply generative AI (GenAI) to augment research – accelerating time to market, reducing costs, and improving patient outcomes. 

As competition increases, life sciences organizations are even more dependent upon innovation to create value. Now, GenAI is ready to undergo ‘clinical trials’ of its own, the outcomes of which promise to revolutionize how enterprises conduct research. 

This paper examines three use cases addressing challenges related to the creation, testing, and approval of new products, as well as ongoing engagements with healthcare professionals about their use.